WHY PHARPOINT RESEARCH?
Mission & Values
Driven by a mission to provide an alternative to rigid, unimaginative, quality-compromised clinical research organizations, PharPoint is dedicated to helping clients improve global health.
PharPoint is a US-based, privately owned CRO that specializes in strategic consulting, clinical operations, project management, biostatistics, and clinical data management services across a wide range of therapeutic areas.
We are uniquely positioned to provide flexible, specialized services to clients of all sizes. Our experience includes clinical development from Phase 1 to Phase 4.
At PharPoint, we put our clients and the patients whose lives they impact at the core of everything we do.
We pride ourselves on excellent customer service, proactive communication, nimble solutions, and an unwavering commitment to operational, regulatory, and scientific excellence.
- Award-winning CRO with best-in-class model
- 900+ clinical trials participated in since 2007
- US based & privately owned
- Accessible senior leadership team averages 22+ years in the industry
- 0% executive turnover rate
- 95% business repeat rate
Recent Industry Recognitions
2020 Triangle Business Journal Life Sciences Award – Company Winner
2019 Scrip Awards Best Specialist CRO – Finalist
Why Choose PharPoint?
No bait-and-switch techniques
PharPoint operates with an honest and transparent approach to staffing and pricing. “Big-box” CROs may make pricing assumptions that are unrealistic, offering a low bid upfront that, by the end of your study, results in amendments that are exponentially higher than the initial price. From the start, PharPoint strives to provide a transparent view of study budgets and timelines.
Quality-focused & client-driven
The PharPoint team is dedicated to providing excellent customer service to help innovators develop life-changing therapies. We see every new study and service as an opportunity to show clients our devotion to quality, and are proud of the relationships this approach builds, with an over 95% business repeat rate.
Nimble & adaptive approach
If your trial partners are unable to quickly adapt and remain flexible, your program may be in danger of excessive delays and economic losses. PharPoint’s success is in part fueled by our willingness to be flexible in our services while simultaneously rigid in our standards. We operate under the understanding that all studies and sponsors are different and require unique solutions.